We serve Chemical Name:2-(3-methylphenyl)ethylhydrazine CAS:32504-15-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-(3-methylphenyl)ethylhydrazine
CAS.NO:32504-15-7
Synonyms:WL 61;3-Methylphenelzine
Molecular Formula:C9H14N2
Molecular Weight:150.22100
HS Code:2928000090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:297.6ºC at 760mmHg
Density:0.994g/cm3
Index of Refraction:1.545
PSA:38.05000
Exact Mass:150.11600
LogP:2.09200
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like WL 61 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Methylphenelzine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methylphenelzine Use and application,3-Methylphenelzine technical grade,usp/ep/jp grade.
Related News: At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good. 2-(3-methylphenyl)ethylhydrazine manufacturer The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. 2-(3-methylphenyl)ethylhydrazine supplier At present, the additional 300 tons of sunniamine, 300 tons of fluoxamic acid, and 200 tons of cyprodinil have been successfully put into production, and the profitability is good. 2-(3-methylphenyl)ethylhydrazine vendor As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 2-(3-methylphenyl)ethylhydrazine factory As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment.
